Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
08/2006
08/30/2006EP1468002B1 Coordination complex
08/30/2006EP1439885B1 Simplified sarcodictyn derivatives as anti-tumor agents
08/30/2006CN1826326A Method for the production of purified 1,3-substituted imidazolium salts
08/30/2006CN1826325A 4,5-dihydro-imidazole as P2X7 ion channel blockers
08/30/2006CN1826310A Novel aminobenzophenone compounds
08/30/2006CN1826111A Imidazole derivatives for treatment of allergic and hyperproliferative disorders
08/30/2006CN1826098A Production of small particles
08/30/2006CN1824655A Method of controlling polymer molecular weight and structure
08/29/2006US7098345 Transamination of orndansetron preparing by Mannich reaction and isolation of product
08/29/2006US7098226 E.g., 1-(2-(1-adamantyl)ethyl)-1-pentyl-3-(3-(4-pyridyl)propyl)urea; useful as therapeutic agents for autoimmune diseases such as rheumatoid arthritis.
08/29/2006US7098215 Nitrogenous compounds and antiviral drugs containing the same
08/29/2006CA2240735C Process for production of piperidine derivatives
08/29/2006CA2112779C Arylsulfonamido-substituted hydroxamic acids
08/29/2006CA2111836C Spin-trapping pharmaceutical compositions and methods for use thereof
08/24/2006WO2006089053A2 Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
08/24/2006WO2006087355A1 1h-imidiazole derivatives as cannabinoid cb2 receptor modulators
08/24/2006WO2006066126A3 Phenol-heterocyclic ligands, metal complexes, and their uses as catalysts
08/24/2006WO2006062972A3 Heterocyclic compounds as inhibitors of factor viia
08/24/2006WO2005004810A3 Arylsulfonamide derivatives
08/24/2006US20060189674 Deacetylase inhibitors
08/24/2006US20060189647 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof
08/24/2006US20060189549 Chalcone derivatives and their use to treat diseases
08/24/2006US20060188554 Transdermal absorption preparation
08/24/2006CA2597896A1 1h-imidazole derivatives as cannabinoid cb2 receptor modulators
08/24/2006CA2597616A1 Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
08/23/2006EP1693365A1 Inhibitors of dipeptidyl peptidase IV
08/23/2006EP1692502A2 Use of the lipoxin receptor, fprl1, as a tool for identifying compounds effective in the treatment of pain and inflammation
08/23/2006EP1692113A1 Aryl imidazoles and their use as anti-cancer agents
08/23/2006EP1480956B1 Halogen-free ionic liquids
08/23/2006EP1324741B1 Method of dyeing keratin-containing fibres
08/23/2006EP1244646B1 Dinitrile intermediates for the synthesis of omapatrilat and methods for producing same
08/23/2006EP1027328B1 Substituted anilides
08/23/2006CN1821228A Pyruvic acid type ionic liquid and its preparing method
08/23/2006CN1821227A Process for preparing ionic liquid
08/23/2006CN1821217A Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative
08/23/2006CN1271068C Novel method for preparing olmesartan
08/23/2006CN1271059C Cyano substituted heterocyclic ketene semiamine contained molecular material and its preparation method
08/23/2006CN1271051C Aza aromatic ring substitutional four branched functional molecule material and preparation method
08/23/2006CN1270692C Use of cationic phenyl-ozo-phenyl compound for dyeing keratin fiber, dye composition and dyeing method
08/22/2006US7094911 Biphenyl and biphenyl-analogous compounds as integrin antagonists
08/22/2006US7094901 Useful as a cocatalyst for addition coordination polymerization comprising an anion containing at least two Lewis basic sites which are coordinated to Lewis acids, and further containing a hydroxyl group for support attachment
08/22/2006US7094807 Viricides; hepatitis virus
08/22/2006US7094801 Inhibiting the expression of VCAM-1; treating inflammatory disorders including rheumatoid arthritis, atherosclerosis, COPD, asthma, allergic rhinitis and restinosis
08/22/2006US7094797 Organ fibrosis inhibitor
08/22/2006CA2240927C Process for production of piperidine derivatives
08/17/2006WO2006085510A1 Remedy for irritable bowel syndrome
08/17/2006WO2006084761A1 Crystalline polymorphs of benazepril hydrochloride
08/17/2006WO2006012513A3 High stability diionic liquid salts
08/17/2006WO2005086895A3 Ion channel modulators
08/17/2006US20060183918 Beta 2-adrenergic receptor agonists
08/16/2006EP1689703A1 Resolution of 3-amino alkylnitriles
08/16/2006EP1689698A1 Bis-cationic compounds and use thereof
08/16/2006EP1689231A2 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives
08/16/2006EP1509525B1 Process for preparing xanthine phosphodiesterase v inhibitors and precursors thereof
08/16/2006EP1337247B1 Use of Gaboxadol for the treatment of premenstrual disorder, postnatal depression or postmenopausal related dysphoric disorder
08/16/2006CN1819996A Naphthylene derivatives as cytochrome P450 inhibitors
08/16/2006CN1817868A Group of ornidazole deriative for preventing anaerobe infection and production thereof
08/16/2006CN1269824C Production of ionic liquids
08/16/2006CN1269819C Synthesis of temozolomide and analogs
08/16/2006CN1269805C 4-(phenyl-piperazinyl-methyl)benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestional disorders
08/16/2006CN1269804C Metalloproteinase inhibitors
08/15/2006US7091380 Bradykinin B1 antagonists or inverse agonists, for prophylaxis and therapy of pain and inflammation
08/15/2006US7091362 Process for preparing nuclear-fluorinated aromatics
08/15/2006US7091341 Adding to a reaction medium comprising isocyanates a catalytic system which comprises imidazole or one of its derivatives;allowing the reaction to progress; isolating polyisocyanurate polyisocyanates
08/15/2006US7091240 Destroying tumor cell vasculation; antitumor agents; anticancer agents
08/15/2006US7091232 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
08/15/2006US7091223 Autoimmune diseases; anticancer agents
08/15/2006US7091219 Administering an effective amount of bis-sulfonamide hydroxyethyl-amino derivative to a HIV patient to prevent the viral replication
08/15/2006US7090756 Controller for redox system
08/15/2006US7090703 oxidation base hair dye; nontoxic, colorfast
08/15/2006CA2215476C Arginine analogues having nitric oxide synthase inhibitor activity
08/10/2006WO2006083271A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/10/2006WO2006083003A1 Novel benzamidine compound
08/10/2006WO2006082309A1 1-h-pyrrole-2-carboxamides and imidazole-5-carboxamides and use thereof as fak, kdr and tie2 kinase modulators for the treatment of cancer
08/10/2006WO2006081807A2 Method for the production of losartan
08/10/2006US20060178417 4-[6(2,2-dimethylpropanoyloxy)indan-1-ylmethyl]1H-imidazole, an alpha 2 adrenergic agonist, for the treatment of hypertension, glaucoma, headaches, diarrhea, ischemia, drug abuse and dependence, hypotension, shock, congestive heart failure, anxiety, as decongestants, analgesics or as sedatives
08/10/2006US20060178414 Treating rheumatoid arthritis, psoriasis, reperfusion injury, cardiovascular , autoimmune, inflammatory disorders and bronchial asthma; e.g., 2-Methoxynaphthalene-1-carboxylic acid benzyl-indan-2-yl-amide
08/10/2006US20060178356 Treating oxidative stress-related conditions typically responsive to cellular enzyme modulation with a substituted phenolic compound having unsaturated groups, e.g. 1-((3-methyl-5-oxo-2-pyrazolin-1-yl), 4-(3-methoxy-4-hydroxy-phenyl)-vinyl-)benzene; skin disorders; antiischemic and cardiotonic agents
08/10/2006US20060178345 Substituted alcohols useful in treatment of Alzheimer's disease
08/10/2006US20060177621 O-coordinated metal chelates and their use in optical recording media having high storage capacity
08/10/2006DE102005003115A1 Verfahren zur Abdichtung rotierender Wellen A process for sealing rotating shafts
08/10/2006CA2595987A1 1-h-pyrrole-2-carboxamides and imidazole-5-carboxamides and use thereof as fak, kdr and tie2 kinase modulators for the treatment of cancer
08/10/2006CA2595962A1 Method for the production of losartan
08/10/2006CA2595789A1 Compounds and compositions as ppar modulators
08/10/2006CA2566809A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/09/2006EP1687268A1 Benzylether amine compounds useful as ccr-5 antagonists
08/09/2006EP1687256A1 Novel phenoxyacetamide derivatives and use thereof for the preparation of diphenylamines
08/09/2006EP1686990A2 2-guanidinylimidazolidinedione compounds and methods of making and using thereof
08/09/2006EP1276743B1 Ion liquids derived from lewis acid based on titanium, niobium, tantalum or antimony, and uses thereof
08/09/2006EP0988301B1 Imidazolyl-cyclic acetals
08/09/2006CN1814592A New derivatives of erythromycin, their preparation process and their use as medicaments
08/09/2006CN1268615C Substituted benzoylcyclohexenones
08/08/2006US7087764 Reacting 2,5-disubstituted-phenylalkylsulfide compound with halogenating agent to produce 2,5-disubstituted-phenylsulfenylhalide compound
08/08/2006US7087763 Forming a compound with acrylate or methacrylate group
08/08/2006US7087762 Long-lasting antimicrobial reaction product of allantoin and formaldehyde containing a low level of free formaldehyde
08/08/2006US7087751 Diazotizing 5-amino-1H-imidazole-4-carboxamide derivative having divalent protecting group on amide that is readily removable by hydrolysis or hydrogenolysis
08/08/2006US7087579 Human sodium glucose co-transporter 2 (SGLT2) inhibitors; hypoglycemic agents, antidiabetic agents; obesity; prodrugs
08/03/2006WO2006080519A1 Diamine derivative
08/03/2006WO2006080481A1 Multiple unit oral sustained release preparation and process for production of the same
08/03/2006US20060173191 Transesterification process for production of (meth)acrylate ester monomers